CRIMINAL LAWAND PROCEDURE
117
(a) “Sexually violent predator,” for purposes
of IC 35-38-1-7.5, has the meaning set forth in IC
35-38-1-7.5(a).
(b) “Sexually violent predator,” for purposes
of IC 35-42-4-10, has the meaning set forth in IC
35-42-4-10(b).
35-31.5-2-304. “Sexually violent predator
defendant” defined.
“Sexually violent predator defendant,” for
purposes of IC 35-33-8-3.5, has the meaning set
forth in IC 35-33-8-3.5(b).
35-31.5-2-307. “Social networking web site”
defined.
“Social networking web site means an Internet
web site, an application, a computer program, or
software that:
(1) facilitates the social introduction
between two (2) or more persons;
(2) requires a person to register or create
an account, a username, or a password to
become a member of the web site and to
communicate with other members;
(3) allows a member to create a web page
or a personal profile; and
(4) provides a member with the opportu-
nity to communicate with another person.
The term does not include an electronic mail pro-
gram or message board program.
35-31.5-2-311. “State” defined.
(a) “State”, for purposes of IC 35-48-7, has the
meaning set forth in IC 35-48-7-7.5.
(b) “State”, for purposes of IC 35-37-5, has the
meaning set forth in IC 35-37-5-1.
35-31.5-2-314. “Store” defined.
“Store” means a place of business where prop-
erty or service with respect to property is dis-
played, rented, sold, or offered for sale.
35-31.5-2-321. “Synthetic drug” defined.
“Synthetic drug” means:
(1) a substance containing one (1) or more
of the following chemical compounds,
including an analog of the compound:
(A) JWH-015 ((2-Methyl-1-propyl-
1H-indol-3-yl)
naphthalenylmethanone).
(B) JWH-018 (1-pentyl-3-(1-naph-
thoyl)indole).
(C) JWH-019 (1-hexyl-3-(naphthalen-
1-oyl)indole).
(D) JWH-073 (naphthalen-1-yl-(1-
butylindol-3-yl)methanone).
(E) JWH-081 (4-methoxynaphthalen-
1-yl- (1-pentylindol- 3yl)
methanone).
(F) JWH-122 (1-Pentyl-3-(4-methyl-1-
naphthoyl)indole).
(G) JWH-200 ((1-(2-morpholin-4-
ylethyl)indol-3-yl)- naphthalen-1-yl-
methanone).
(H) JWH-250 (1-pentyl-3-(2-methoxy-
phenylacetyl)indole).
(I) JWH-251 (1-pentyl-3-(2-methyl-
phenylacetyl)indole).
(J) JWH-398 (1-pentyl-3-(4-chloro-
1-naphthoyl)indole).
(K) HU-210 ((6aR,10aR)- 9-(Hydroxy-
methyl)- 6,6-dimethyl- 3-(2-methy-
loctan-2-yl)-6a,7,10,10a-tetrahydroben
zo [c]chromen- 1-ol).
(L) HU-211 ((6aS,10aS)-9-(Hydroxy-
methyl)- 6,6-dimethyl- 3-(2-methy-
loctan-2-yl)-6a,7,10,10a-tetrahydroben
zo [c]chromen-1-ol).
(M)HU-308 ([(1R,2R,5R)-2-[2,6-
dimethoxy-4- (2-methyloctan- 2yl)
phenyl]-7,7-dimethyl-4-bicylo[3.1.1]
hept-3-enyl] methanol).
(N) HU-331 (3-hydroxy-2- [(1R,6R)-
3-methyl-6- (1-methylethenyl)-
2-cyclohexen-1-yl]-5 -pentyl-2,5
-cyclohexadiene-1,4-dione).
(O) CP 55,940 (2-[(1R,2R,5R)-5-
hydroxy-2-(3-hydroxypropyl)
cyclohexyl]- 5- (2-methyloctan-2
-yl)phenol).
(P) CP 47,497 (2-[(1R,3S)-3-hydrox-
ycyclohexyl]- 5- (2-methyloctan-2-yl)
phenol) and its homologues, or 2-
[(1R,3S)-3-hydroxycyclohexyl]-5-(2-
methyloctan-2-yl) phenol), where side
chain n=5, and homologues where side
chain n=4, 6, or 7.
(Q) WIN 55212-2 ((R)-(+)-[2,3-
Dihydro-5-methyl-3-(4-morpholinyl-
methyl) pyrrolo [1,2,3-de)- 1,4-
